Trendlines associate company in talks to be sold for US$16m
Proposed sale will result in delisting of ETView from Tel Aviv bourse
Singapore
CATALIST-listed Trendlines Group said on Friday that its 26.46 per cent-owned associated company ETView Medical could soon be acquired for US$16 million - in what would be the medical tech (medtech) incubator's first exit of a portfolio company since it listed on the Singapore Exchange in November 2015.
Trendlines said that ETView, which manufactures airway visualisation products for medical professionals, has reported to the Tel Aviv Stock Exchange (TASE) that it is in an advanced stage of negotiations with an international company, with the intention to sign a definitive agreement "as soon as possible" to sell ETView to the international company.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Intel slides after tepid forecast spurs fears about comeback
Microsoft beats estimates as AI drives revenue
Crypto firm sues SEC to fend off oversight of Ethereum
Snap beats first-quarter expectations, shares jump 25%
Google parent announces first-ever dividend; beats on sales, profit; shares soar
Baltimore’s trapped ships start leaving as new channel opens